Step Down FSH Approach and Late Follicular Phase in Progesterone Level (FSH)
Impact of Step-down Approach During Late Follicular Phase in Recombinant FSH-stimulation Dosage for IVF on Progesterone Level on the Day of Final Oocyte Maturation
Sponsor: ART Fertility Clinics LLC
This EARLY_PHASE1 trial investigates Progesterone Resistance and is currently completed. ART Fertility Clinics LLC leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Oct 2020 — Nov 2020 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Apr 2020 — Oct 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting EARLY_PHASE1
-
Mar 2019 — Mar 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2018 — Mar 2019 [monthly]
Recruiting EARLY_PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Mar 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ART Fertility Clinics LLC
- Merck Serono International SA
For direct contact, visit the study record on ClinicalTrials.gov .